Can talking it out ease PTSD in cancer patients during a pandemic?
NCT ID NCT04747249
First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This study tested whether monthly 45-minute psychological interviews over 6 months could reduce post-traumatic stress symptoms in cancer patients affected by the COVID-19 pandemic. It included 29 adults with solid tumors who had moderate to high PTSD symptoms. The goal was to see if this supportive therapy could lower stress, improve resilience, and enhance sleep and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- psychological support (monthly interviews)
- What this could lead to
- If it works, this could point toward a simple, supportive therapy to reduce PTSD and improve quality of life for cancer patients during health crises.
- What could go wrong
- This is a very small, completed study with only 29 participants and no control group, so results may not apply broadly. The intervention is brief and may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Francois Baclesse
Caen, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shield nerves from Chemotherapy's side effects?
- Can a Tumor's DNA guide better cancer care for kids?
- Can a new PET tracer reveal a key cancer target?
- Can a smart drug home in on Hard-to-Treat cancers?
- Can a new tracer light up cancer growth?
- Can a Dual-Pronged antibody outsmart advanced cancers?